MEK
MEK es una quinasa de doble especificidad que juega un papel central en la vía de señalización MAPK/ERK al activar ERK mediante fosforilación. La señalización de MEK es crucial para regular el crecimiento, la supervivencia y la diferenciación celular. La actividad aberrante de MEK se ha implicado en diversos cánceres y trastornos del desarrollo, lo que la convierte en un objetivo terapéutico importante. En CymitQuimica, ofrecemos una variedad de inhibidores y moduladores de MEK para apoyar su investigación en oncología, señalización celular y desarrollo terapéutico.
Se han encontrado 74 productos para "MEK".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
MEK inhibitor
CAS:MEK inhibitor is a MEK receptor and cell cycle protein/CDK complex inhibitor with antitumor activity that can be used to study tumor cell proliferation.Fórmula:C26H26N4O2Pureza:97.48%Forma y color:SolidPeso molecular:426.51RO4927350
CAS:RO4927350 is a potent, selective MEK1/2 inhibitor, blocking MAPK pathway in vitro/vivo and showing notable antitumor effects.Fórmula:C27H28N4O6SForma y color:SolidPeso molecular:536.6Cobimetinib racemate
CAS:Cobimetinib racemate (Cobimetinib (racemate)) (GDC-0973 racemate) is a selective inhibitor of MEK.Cobimetinib racemate is also known as a mitogen-activatedFórmula:C21H21F3IN3O2Pureza:98.00% - 99.71%Forma y color:SolidPeso molecular:531.31MEK-IN-6 hydrate
CAS:MEK-IN-6 hydrate (compound 69), a MEK inhibitor, exhibits an IC50 value of 2 nM in A375 cells [1].Fórmula:C18H22FN3O5SPureza:98%Forma y color:SolidPeso molecular:411.45MS934
CAS:MS934, a novel VHL-recruiting MEK 1/2 degrader, exhibits potent anti-proliferative effects on HT-29 cell growth, achieving a GI50 of 0.023 μM.Fórmula:C52H69F3IN7O6SPureza:98%Forma y color:SolidPeso molecular:1104.11Nedometinib
CAS:Nedometinib (NFX-179) is a MEK1 inhibitor with anticancer and antitumor activities, which can be used to study malignant tumors.Fórmula:C17H16FIN4O3Pureza:99.18%Forma y color:SolidPeso molecular:470.24Ref: TM-T78209
1mg66,00€5mg145,00€1mL*10mM (DMSO)150,00€10mg215,00€25mg353,00€50mg537,00€100mg708,00€GSK1790627
CAS:GSK1790627, the N-deacetylated metabolite of Trametinib, represents an orally active MEK inhibitor that promotes autophagy and triggers apoptosis [1].Fórmula:C24H21FIN5O3Forma y color:SolidPeso molecular:573.36Atebimetinib
CAS:Atebimetinib, Oral MEK inhibitor, suppresses MAPK signaling, for combination therapy in metastatic pancreatic cancer and NSCLC.Fórmula:C23H27FN4O6SPureza:99.40%Forma y color:White SolidPeso molecular:506.55MEK4 inhibitor-2
CAS:MEK4 Inhibitor-2, a novel MEK4 inhibitor, demonstrates efficacy against pancreatic adenocarcinoma, exhibiting an IC50 value of 83 nM.Fórmula:C20H15FN4O3SForma y color:SolidPeso molecular:410.42Luvometinib
CAS:Luvometinib is an inhibitor of the mitogen-activated protein kinase (MEK) with antitumor activity.Fórmula:C26H22F2IN5O4SForma y color:SolidPeso molecular:665.45Refametinib R enantiomer
CAS:Refametinib R enantiomer (RDEA119 R enantiomer) is an MEK inhibitor with an EC50 of 2.0-15 nM.Refametinib (R enantiomer) has anticancer activity and can be usedFórmula:C19H20F3IN2O5SPureza:99.86%Forma y color:Yellow SolidPeso molecular:572.34MEK1/2-IN-2
MEK1/2-IN-2 is a potent, ATP-competitive MEK1/2 inhibitor that exhibits equal inhibitory effects on wild-type MEK1/2 and a group of MEK1/2 mutant cells.Fórmula:C28H22ClFN6OForma y color:SolidPeso molecular:512.97EBI-1051
CAS:EBI-1051 is a highly potent and orally efficacious inhibitor of MEK (IC50: 3.9 nM).Fórmula:C18H15F2IN2O5Pureza:98%Forma y color:SolidPeso molecular:504.22G-479
CAS:G-479, a potent MEK inhibitor and improved analogue of GDC-0623, has distributed polarity enhancing bioactivity.Fórmula:C16H15FIN5O4Forma y color:SolidPeso molecular:487.22
